UPC_APP_18039/2025

NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

Procedural & sub-applicationsOther ProceduralThe Hague LDGeneric application—

Overview Decisions Documents Timeline

Parties

Claimants

Arbutus Biopharma Corporation
Genevant Sciences GmbH

Reps: Markus van Gardingen (Not specified)

Respondents

Moderna Belgium S.R.L.(Moderna Group)
Moderna Denmark ApS(Moderna Group)
Moderna Portugal Unipessoal LDA(Moderna Group)
Moderna Poland SP. Z.O.O.(Moderna Group)
Moderna Netherlands B.V.(Moderna Group)
Moderna Biotech UK Limited(Moderna Group)
Moderna Italy S.R.L.(Moderna Group)
Moderna France SASU(Moderna Group)
Moderna Biotech Spain SL(Moderna Group)
Moderna Germany GmbH(Moderna Group)
Moderna Sweden AB(Moderna Group)
Moderna Norway AS(Moderna Group)
ModernaTX, Inc.(Moderna Group)
Moderna, Inc.(Moderna Group)
Moderna Switzerland GmbH(Moderna Group)

Reps: Ruben Laddé (Not specified); Joachim Renken (Not specified)

Judges

Not SpecifiedJudge-Rapporteur (The Hague Local Division)

Patents

EP 2 279 254
EP 4 241 767

CPC codes: C07J9/00, A61P31/14, A61K9/1271, C12N15/111, C12N2310/14, C12N15/113, A61K9/1272, A61P35/00, A61K31/713, C12N2320/32, A61P31/12, C12N15/1137…

Sector: Biotechnology

Outcome

Procedural only

Filed: —

First decided: Apr 17, 2025

Language: —